Omeros (OMER) EBITDA Margin Growth (3y) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 78,093.00 |
| Jun 30, 2021 | 193,681.00 |
| Mar 31, 2021 | 172,596.00 |
| Dec 31, 2020 | -23,029.00 |
| Sep 30, 2020 | -11,274.00 |
| Jun 30, 2020 | -16,235.00 |
| Mar 31, 2020 | -24.00 |
| Dec 31, 2019 | 6,467.00 |
| Sep 30, 2019 | 6,854.00 |
| Jun 30, 2019 | 7,205.00 |
| Mar 31, 2019 | 16,506.00 |
| Dec 31, 2018 | 19,013.00 |
| Sep 30, 2018 | -24,534.00 |
| Jun 30, 2018 | -151,264.00 |
| Mar 31, 2018 | 291,903.00 |
| Dec 31, 2017 | 1.14 Mn |
| Sep 30, 2017 | 852,947.00 |
| Jun 30, 2017 | 3.99 Mn |
| Mar 31, 2017 | 1.65 Mn |
| Dec 31, 2016 | 93,959.00 |
| Sep 30, 2016 | 695,285.00 |
| Jun 30, 2016 | 958,250.00 |
| Mar 31, 2016 | 68,106.00 |
| Dec 31, 2015 | 19,155.00 |
| Sep 30, 2015 | 32,565.00 |
| Jun 30, 2015 | 3,619.00 |
| Mar 31, 2015 | -421,701.00 |
| Dec 31, 2014 | -1.06 Mn |
| Sep 30, 2014 | -790,424.00 |
| Jun 30, 2014 | -3.95 Mn |
| Mar 31, 2014 | -1.61 Mn |
| Dec 31, 2013 | -21,497.00 |
| Sep 30, 2013 | -412,771.00 |
| Jun 30, 2013 | -817,256.00 |